Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients

ArticleinTransplantation 77(9):1480 · June 2004with7 Reads
Impact Factor: 3.83 · DOI: 10.1097/01.TP.0000123081.81022.33 · Source: PubMed